Rainer Ng
About Rainer Ng
Rainer Ng serves as the Director of Technology Development at Baebies, where he has worked since 2015. He holds a Ph.D. in Bioengineering from the University of Michigan and has extensive experience in leading research and development efforts in molecular capabilities and diagnostics.
Work at Baebies
Rainer Ng has served as the Director of Technology Development at Baebies since 2015. In this role, he monitors and evaluates new technology trends to assess their potential applicability to Baebies products. He leads research initiatives aimed at expanding molecular capabilities, including the development of ultrafast PCR and the establishment of multiplexing infrastructure. Ng manages a team of 12 scientists and engineers, focusing on the development of assays and enabling technologies for next-generation analyzers and test panels. His leadership ensures that research and development efforts align with the company's strategic goals.
Education and Expertise
Rainer Ng holds a Bachelor of Engineering (B.E.) in Chemical Engineering from the University of Michigan, where he studied from 1999 to 2003. He further advanced his education at the same institution, earning a Doctor of Philosophy (Ph.D.) in Bioengineering and Biomedical Engineering from 2003 to 2008. His academic background provides a solid foundation for his expertise in technology development and molecular diagnostics.
Background
Before joining Baebies, Rainer Ng worked at GlaxoSmithKline as a Principal Investigator from 2012 to 2015 in Durham, North Carolina. His earlier experience includes a position as a Post Doctoral Scientist at the University of Washington from 2008 to 2012 in Seattle, WA. This diverse background in both industry and academia has equipped him with a comprehensive understanding of research and development in the biomedical field.
Achievements
Rainer Ng has overseen technical work from granting agencies and strategic partners, managing projects totaling over $25 million. He has ideated research topics to secure external funding, ensuring that R&D efforts remain cost-neutral to Baebies. Notably, he developed a sepsis diagnostic platform that significantly reduces the time required to return positive blood culture results compared to existing products.